Schedule 13G ownership disclosure

BRIACELL THERAPEUTICS CORP

Security class unavailable · CUSIP: 107930109

Event date: 2024-09-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-100052
Form type
SC 13G
Filer
BriaCell Therapeutics Corp.
CIK
CIK 1610820
Filed
Sep 16, 2024
Reporting period
Sep 11, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G | SEC Filings Hub